Tigecycline 50mg IV Injection | Tigebax - Glenmark

Advanced Broad-Spectrum Antibiotic Therapy When treating complicated skin and skin structure infections (cSSSI) or complicated intra-abdominal infections (cIAI) where other treatments have failed or are contraindicated, healthcare providers require a potent, highly effective clinical intervention. The Tigecycline Injection I.P. 50 mg (commercially recognized as Tigebax) provides targeted, active antibiotic therapy designed strictly for intravenous (IV) administration. Manufactured by Glenmark, a highly respected leader in global pharmaceuticals, this single-use lyophilized vial ensures the robust clinical performance necessary for critical antimicrobial protocols.

Why Choose Tigebax for Clinical Care? Tackling severe bacterial infections—including those caused by multi-drug resistant pathogens—requires an advanced glycylcycline antibiotic like Tigecycline. It works powerfully by inhibiting protein translation in bacteria, effectively halting their growth and spread. Clinical specialists rely on Tigebax because its lyophilized (freeze-dried) presentation preserves the stability and maximum potency of the active ingredient until it is ready to be reconstituted and infused in a controlled hospital setting.

Key Product Specifications & Clinical Benefits

Potent Active Ingredient: Each vial contains precisely 50 mg of Tigecycline I.P., ready for clinical reconstitution.

Targeted Intravenous Delivery: Formulated exclusively For Intravenous use only (For IV), ensuring rapid systemic distribution and immediate clinical onset.

Lyophilized Formulation: Supplied as a freeze-dried powder to maximize shelf-life and stability prior to clinical prep.

Single-Use Protocol: Packaged strictly for single use. Practitioners must appropriately discard any unused portion after reconstitution.

Essential Storage & Usage Guidelines Maintaining the integrity of this antibiotic injection is vital for clinical efficacy and patient safety.

Reconstitution Warning: Carefully inspect the solution after reconstitution. Caution: Not to be used if reconstituted solution contains visible solid particles.

Preparation: Refer strictly to the enclosed package insert for detailed reconstitution instructions, compatible diluents, and exact infusion times.

Important Notice: Tigebax is a Schedule H Prescription Drug. Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner. It must be prescribed, handled, prepared, and administered strictly by healthcare professionals in a clinical or hospital setting.